CNOOC Limited Announces Its 2025 Business Strategy and Development Plan

CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces its business strategy and development plan for the year 2025. https://mma.prnewswire.com/media/2051221/CNOOC_Logo_Logo.jpg — Maintain stable capital expenditure, with net production set to exceed 2 million barrels of oil equivalent (BOE) per day — Annualpayout ratio will be no less than […]

Sustainable solutions have the potential to reap huge energy savings across video entertainment industry

(NASDAQ:IDCC), Research from Futuresource and InterDigital estimates that the TV and video streaming industry accounts for 4% of total global emissions – double that of the aviation industry, at 2% Sustainable solutions such as Pixel Value Reduction (PVR) technology have the potential to reap huge energy savings if applied to events such as the Olympics

ITC London: Duck Creek Technologies Hosts “Forecasting the Future of Commercial Lines Insurance” Roundtable

LONDON, Jan. 22, 2025 (GLOBE NEWSWIRE) — Duck Creek Technologies, the global intelligent solutions provider redefining the future of property and casualty (P&C) and general insurance, will join partners and industry leaders at ITC London taking place 27-28 January at The Brewery in London. In addition to exhibiting, Duck Creek Director of Solution Architecture Matt

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178 colorectal cancer patient samples Data to be presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Cambridge, UK, 21 January 2025 – Panakeia (“the Company”), a pioneer in AI-driven multi-omic biomarker profiling, today announces it

ENA Respiratory Successfully Completes Phase Ib Dosing of Antiviral Host Defense Immune Enhancer INNA-051 Dry Powder Formulation in Older Adults and Advances Study in Young Adults

New intranasal formulation with significantly improved stability was well-tolerated and led to local activation of innate immune pathways in adults aged >60 U.S. Department of Defense (DOD) funded study extension into younger adults aged 18 – 45 will complete dosing in January MELBOURNE, Australia, Jan. 22, 2025 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical

LANZAJET SELECTS TEESSIDE’S WILTON INTERNATIONAL FOR ITS NEXT SUSTAINABLE AVIATION FUEL PRODUCTION FACILITY – PROJECT SPEEDBIRD

LanzaJet, a leader in Sustainable Aviation Fuel (SAF)1 technology and producer of SAF, today announced the selection of the site for their next production facility, Project Speedbird, in Teesside's Wilton International. https://mma.prnewswire.com/media/2410446/LJ_black_Logo.jpg LanzaJet has partneredwith Sembcorp Utilities (UK) Limited, a wholly-owned entity of Sembcorp Industries Ltd,to develop an ethanol-to-SAF facility at Wilton Internationalin Teesside, UK.

Trina Storage Releases Insightful White Paper on Advanced Battery Cell Technology for Energy Storage Systems

Trina Storage, a global leader in energy storage solutions, proudly unveils its latest White Paper: Advanced Battery Cells for Energy Storage Systems. This forward-looking publication delivers an in-depth examination of state-of-the-art battery cell technologies and their transformative role in shaping the future of energy storage. By addressing key innovations, market trends, and technical advancements, the

Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company

Eisai Co., Ltd. announced today that it has been listed in the 2025 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's ninth inclusion on the list. Ranked 35th, Eisai is the highest ranking among global pharmaceutical companies.

Scroll to Top